Results in Journal Drug Designing & Intellectual Properties International Journal: 48
(searched for: journal_id:(4148092))
Published: 8 June 2019
Drug Designing & Intellectual Properties International Journal, Volume 3, pp 293-327; doi:10.32474/ddipij.2018.03.000155
Abstract:
Alginates are polysaccharides. The commercially available ones come from brown algae
Published: 25 March 2019
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-8; doi:10.32474/ddipij.2019.02.000149
Published: 26 February 2019
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-2; doi:10.32474/ddipij.2019.02.000148
Published: 22 February 2019
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-10; doi:10.32474/ddipij.2019.02.000146
Published: 12 February 2019
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-2; doi:10.32474/ddipij.2019.02.000147
Published: 13 November 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-9; doi:10.32474/ddipij.2018.02.000145
Published: 24 October 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-3; doi:10.32474/ddipij.2018.02.000144
Published: 23 October 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-6; doi:10.32474/ddipij.2018.02.000143
Published: 16 October 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-3; doi:10.32474/ddipij.2018.02.000142
Published: 15 October 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-3; doi:10.32474/ddipij.2018.02.000141
Published: 3 October 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-5; doi:10.32474/ddipij.2018.02.000140
Published: 18 September 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-10; doi:10.32474/ddipij.2018.02.000138
Published: 10 September 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-10; doi:10.32474/ddipij.2018.02.000139
Published: 10 September 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-6; doi:10.32474/ddipij.2018.02.000137
Published: 10 September 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-4; doi:10.32474/ddipij.2018.02.000136
Published: 4 September 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-6; doi:10.32474/ddipij.2018.02.000135
Published: 4 September 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-3; doi:10.32474/ddipij.2018.02.000134
Published: 4 September 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-2; doi:10.32474/ddipij.2018.02.000133
Published: 27 August 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-4; doi:10.32474/ddipij.2018.02.000132
Published: 21 August 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-4; doi:10.32474/ddipij.2018.02.000131
Published: 30 July 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-9; doi:10.32474/ddipij.2018.02.000130
Published: 26 July 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-4; doi:10.32474/ddipij.2018.02.000129
Published: 25 July 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-2; doi:10.32474/ddipij.2018.02.000128
Published: 25 July 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-3; doi:10.32474/ddipij.2018.02.000127
Abstract:
During the last decades, life science startup companies have relatively rapidly increased their presence in the pharmaceutical landscape. Pharmaceutical
Published: 20 July 2018
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-2; doi:10.32474/ddipij.2018.02.000126
Published: 11 July 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-9; doi:10.32474/ddipij.2018.01.000125
Abstract:
As of late, vesicles have turned out to become the vehicle of choice in drug delivery. Lipid vesicles have important role in improving bioavailability for existing drugs
Published: 2 July 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-3; doi:10.32474/ddipij.2018.01.000124
Abstract:
Inability to early diagnosis is a major concern for the treatment of fatal disease like cancer. Early diagnosis and treatment enhances the scope of disease curability
Published: 2 July 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-4; doi:10.32474/ddipij.2018.01.000123
Published: 18 June 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-3; doi:10.32474/ddipij.2018.01.000121
Abstract:
On November 21, 2010, a four-year-old girl visited the emergency room of Kyungpook national university hospital and could not receive treatment because she did not have a pediatrician
Published: 18 June 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-5; doi:10.32474/ddipij.2018.01.000122
Published: 11 June 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-4; doi:10.32474/ddipij.2018.01.000120
Published: 29 May 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-3; doi:10.32474/ddipij.2018.01.000119
Published: 17 May 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-3; doi:10.32474/ddipij.2018.01.000118
Published: 10 May 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-3; doi:10.32474/ddipij.2018.01.000116
Published: 10 May 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-2; doi:10.32474/ddipij.2018.01.000115
Published: 9 May 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-18; doi:10.32474/ddipij.2018.01.000114
Published: 4 May 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-5; doi:10.32474/ddipij.2018.01.000113
Published: 19 April 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-6; doi:10.32474/ddipij.2018.01.000111
Published: 13 April 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-3; doi:10.32474/ddipij.2018.01.000110
Abstract:
During the last decade, and exponentially over the last three years, numerous pharmaceutical manufacturing plants have closed their doors following current
Published: 4 April 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 001-005; doi:10.32474/ddipij.2018.01.000109
Published: 4 April 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 001-008; doi:10.32474/ddipij.2018.01.000108
Published: 29 March 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 001-014; doi:10.32474/ddipij.2018.01.000107
Published: 29 March 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 001-0013; doi:10.32474/ddipij.2018.01.000106
Published: 27 March 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 001-014; doi:10.32474/ddipij.2018.01.000105
Published: 26 March 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 001-006; doi:10.32474/ddipij.2018.01.000104
Published: 19 March 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 001-004; doi:10.32474/ddipij.2018.01.000102
Published: 19 March 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 001-003; doi:10.32474/ddipij.2018.01.000103
Abstract:
The design of micro particulate drug delivery systems is an efficient technique to provide the sustained & controlled delivery of drugs over long periods of time
Published: 24 January 2018
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 001-005; doi:10.32474/ddipij.2018.01.000101